Michael K. McGarrity – Chief Executive OfficerMr. McGarrity has more than 30 years of experience in the healthcare industry, both in devices and diagnostics. Michael spent 13 years with Stryker Corporation, where he served in leadership roles in sales, marketing and strategic development, most recently including Vice President of Marketing for Stryker Instruments. In this position, Mr. McGarrity was responsible for marketing strategy and growth, guiding the Company into markets such as post-operative pain management, surgical fluid waste management and interventional pain management. He also had executive general management responsibility for a newly created business focused on interventional spine pain management.
Mr. McGarrity then joined Nanosphere Incorporated, a nanotechnology based molecular diagnostics company, where he took over as CEO in February of 2013 and engineered a turnaround of the company resulting in a successful sale of the company to Luminex in 2016. Mr. McGarrity is a graduate of the University of Notre Dame and began his career in commercial banking in Chicago.
Jeffrey H. Bell – Chief Financial OfficerJeffrey H. Bell founded the Company in June 2011 and serves as President and Chief Financial Officer. Prior to founding Sterilis, Mr. Bell acted as Chief Operating Officer of an Australian based listed medical device company, Norwood Abbey Limited. During this time Mr. Bell was directly involved or responsible for raising in excess of $100M through various equity, debt and quasi-debt securities. both in-license and out-license agreements for a variety of medical device and immunotherapeutic technologies. negotiating the successful purchase of an ophthalmic product line from Novartis subsidiary CIBA Vision, and the spin out of a subsidiary technology on the London Stock Exchange achieving a tenfold increase in book value upon listing. Prior to joining Norwood, Mr. Bell worked as a Chartered Accountant in Australia for ten years and is an associate member of the Institute of Chartered Accountants in Australia. Mr. Bell has held various Board and Company Secretarial positions in both public and private companies.
John Bellano – Chief Commercial Officer
Mr. Bellano has more than 20 years of experience in the healthcare industry, both pharmaceuticals and molecular diagnostics. Backed by transformational leadership attributes, he has consistently developed and delivered meteoric growth strategies using market centered, metrics driven methodologies. John has spent 13 years in executive leadership roles, most recently Senior Vice President of Sales for AltheaDx, where he led a comprehensive reinvigoration strategy. In 2011, John managed a $35m P&L for Assurex Health while driving sales from $700k to $60M. Additional senior executive roles at Nanosphere, GenMark, and Third Wave Technologies, further reinforce a successful track record of developing and implementing strategies to produce aggressive revenue growth, improved customer experience and retention. Mr. Bellano is a graduate of marketing at De Sales University, Allentown, PA.